Belite Bio (NASDAQ:BLTE) Earns Buy Rating from HC Wainwright
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $100.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 47.73% from the stock’s previous close. Separately, Benchmark lifted […]
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $100.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 47.73% from the stock’s previous close. Separately, Benchmark lifted […]
